Global Digital Pathology Market - 2023-2030

Market Overview

The global digital pathology market reached US$ 0.9 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 1.7 billion by 2030. The global digital pathology market is expected to exhibit a CAGR of 8.7% during the forecast period (2023-2030). The increasing adoption of telepathology and remote consultation is driving up demand for digital pathology market trends.

The digital pathology market is experiencing significant growth and transformation. Digital pathology involves the digitization and management of pathology images, enabling pathologists to access and analyze slides electronically. This technology offers numerous advantages, including improved workflow efficiency, enhanced collaboration, accurate diagnosis, and potential integration with artificial intelligence (AI) algorithms for automated analysis.

The global digital pathology market is driven by the factors such as the increasing prevalence of chronic diseases, integration of artificial intelligence(AI), increasing adoption of digital pathology to enhance lab efficiency, technological advancements in digital pathology systems, the rising geriatric population, and increasing applications of digital pathology in companion diagnostics and drug development.

Market Dynamics

Increasing Adoption of Digital Pathology to Enhance Lab Efficiency Drives the Growth of the Digital Pathology Market

Traditional pathology practices involve the use of physical glass slides that require manual handling, storage, and transportation. This process can be time-consuming and prone to errors. Digital pathology eliminates the need for physical slides and enables pathologists to access and analyze images remotely. This enhances workflow efficiency, reduces turnaround times, and improves the overall productivity of the laboratory.

Digital pathology also facilitates seamless collaboration among pathologists. It allows for easy sharing of images, remote consultations, and second opinions, regardless of geographical location. Pathologists can collaborate in real time, leading to more accurate diagnoses and improved patient outcomes. Moreover, digital pathology enables the integration of artificial intelligence (AI) and machine learning algorithms for automated analysis, further enhancing efficiency and accuracy.

For instance, on June 19, 2023, Sheikh Shakhbout Medical City (SSMC), one of the UAE's largest hospitals and a joint-venture partnership between Abu Dhabi Health Services Company (SEHA) and Mayo Clinic, launched its state-of-the-art, Pathology Laboratory, which will support SSMC's expert-led pathology team in diagnosing disease and complex conditions with the utmost accuracy using AI-powered tools and applications.

Increasing Applications in Companion Diagnostics and Drug Development Also Drive the Growth of the Digital Pathology Market

Companion diagnostics involves using diagnostic tests to identify patients who are likely to respond to a specific therapeutic treatment. Digital pathology plays a crucial role in companion diagnostics by enabling the analysis of tissue samples and biomarkers to determine a patient's eligibility for targeted therapies. Digital pathology platforms provide an accurate and standardized assessment of biomarkers such as genetic mutations or protein expression, which are essential for guiding treatment decisions.

Digital pathology is also making significant contributions to drug development and research. It allows pharmaceutical companies and researchers to analyze the effects of potential drug candidates on tissue samples. Digital pathology platforms offer a standardized and reproducible method for assessing the efficacy and safety of new drugs during preclinical and clinical trials.

By automating image analysis and leveraging AI algorithms, digital pathology assists in identifying and quantifying cellular and molecular changes induced by drug treatments. This accelerates the drug development process and aids in making informed decisions regarding the efficacy and safety of new therapies.

For instance, on June 22, 2023, PharmaNest Inc, a leader in high-resolution quantitative Digital Pathology and Artificial Intelligence, announced the launch of its Digital Pathology spatially resolved, quantitative tissue panels to describe the severity of tissue injury and inflammation in the context of fibrotic conditions and allow novel AI-driven investigations of inflammation in the context of fibrosis for any condition, from discovery models to clinical development.

Limited Standardization will Hamper the Growth of the Market.

Digital pathology is still evolving, and there is a lack of standardization in various aspects, including image formats, metadata, and analytical algorithms. The absence of standardized protocols and guidelines can create challenges in data sharing, comparison, and reproducibility across different platforms and institutions. Efforts towards standardization and collaboration among stakeholders are necessary to overcome these challenges.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the digital pathology market. The pandemic necessitated social distancing measures and reduced in-person interactions, making remote diagnosis and telepathology essential. Digital pathology enabled pathologists to remotely access and analyze pathology images, allowing for continued diagnostic services while minimizing the risk of virus transmission. The demand for remote consultation and telepathology solutions surged during the pandemic, driving the adoption of digital pathology systems.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global digital pathology market. International collaborations and research initiatives in the field of digital pathology could face disruptions due to the conflict. This may affect the progress of joint projects and the sharing of knowledge and resources, potentially slowing down innovation and advancements in the global digital pathology market.

Segment Analysis

The global digital pathology market is segmented based on product, application, type, technology, end-user, and region.

Software from the Product Segment Accounts for 37.9% of the Digital Pathology Market Share

Digital pathology software offers advanced image analysis tools that assist pathologists in quantifying and analyzing tissue samples. These tools can automate certain tasks, such as cell counting, measuring biomarker expression, and identifying specific cellular structures. This enhances the efficiency and accuracy of diagnosis, reducing the reliance on manual analysis.

Software platforms in digital pathology increasingly integrate AI capabilities for automated analysis and pattern recognition. AI algorithms can assist in identifying anomalies, predicting disease outcomes, and providing decision support to pathologists. This integration enhances efficiency, accuracy, and consistency in diagnosis and allows for the discovery of new biomarkers and therapeutic targets.

Digital pathology software provides robust data management and storage capabilities. It enables the creation of centralized repositories for pathology images, patient data, and associated metadata. These repositories serve as valuable resources for research, quality assurance, and educational purposes. Software solutions ensure secure storage, retrieval, and sharing of digital pathology data while adhering to data protection regulations.

For instance, on June 8, 2023, Indica Labs announced the launch of a service offering deployment and ongoing support of its HALO digital pathology software in a fully managed cloud-hosted environment powered by Amazon Web Services (AWS). The service enables organizations to benefit from Indica Labs' software development and cloud deployment expertise while maintaining full ownership and control over their AWS account. Indica Labs' entire suite of HALO software, including the HALO Image Analysis platform, HALO AI deep learning classifier add-on, HALO Link browser-based image management system, and HALO AP anatomic pathology workflow platform, can now be deployed in professionally managed AWS cloud-hosted environments.

Geographical Analysis

North America Accounted for Approximately 39.8% of the Market Share in 2022, Owing to the Advanced Healthcare Infrastructure and Presence of Major Players

North America boasts a well-developed and advanced healthcare infrastructure, including hospitals, diagnostic laboratories, and research institutions. The region has made significant investments in healthcare technologies, including digital pathology, to enhance patient care and diagnostic capabilities. The availability of state-of-the-art facilities and resources facilitates the adoption and implementation of digital pathology systems.

North America is home to several major players in the digital pathology market, including technology providers, software developers, and research organizations. These companies have made substantial investments in research and development, driving technological advancements and innovation in the field. The presence of established players with strong market positions contributes to the overall market growth and dominance of North America.

For instance, in September 2022, INFINITT North America, an award-winning developer of enterprise imaging solutions for healthcare, announced a collaboration with Hamamatsu Corporation to jointly promote Hamamatsu whole slide scanners (NanoZoomers) and INFINITT Digital Pathology Solution (IDPS) to its United States customers.

Competitive Landscape

The major global players in the digital pathology market include: F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Olympus Corporation, Leica Biosystems Nussloch GmbH (Danaher Corporation), Hamamatsu Photonics, Inc., Mikroscan Technologies, Inc., Inspirata, Inc. (Fujifilm), Visiopharm A/S, Huron Technologies International Inc., and ContextVision AB.

Why Purchase the Report?

• To visualize the global digital pathology market segmentation based on product, application, type, technology, end-user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of digital pathology market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global digital pathology market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies